Structured Summary
Abstract
A preparation of insulin and zinc chloride in the form of a crystalline suspension. Typically the duration of ultralente insulin activity lasts between 18-30 hours after dosage.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
1 entry terms
- Insulin, Ultralente
MeSH Record
Aspects Covered
26 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2012; use INSULIN, LONG-ACTING 1966-2011
MeSH Record
Previous Indexing
- Insulin, Long-Acting (1966-2011)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Ultralente Insulin. Medical Subject Headings (MeSH). 2026. Unique ID D061406. http://id.nlm.nih.gov/mesh/2026/D061406
- Ultralente Insulin. In: Wikipedia. https://en.wikipedia.org/wiki/Ultralente_insulin
- Ultralente Insulin. In: Wikidata. https://www.wikidata.org/wiki/Q7880550